OLEMA PHARMACEUTICALS, INC. Increase (Decrease) in Other Operating Assets
OLEMA PHARMACEUTICALS, INC. (OLMA) reported Increase (Decrease) in Other Operating Assets of $1.11 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2023-05-09
- OLEMA PHARMACEUTICALS, INC. increase (decrease) in other operating assets for the quarter ending 2022-12-31 was $0.00.
- OLEMA PHARMACEUTICALS, INC. increase (decrease) in other operating assets for the quarter ending 2022-09-30 was $572.00K.
- OLEMA PHARMACEUTICALS, INC. increase (decrease) in other operating assets for the quarter ending 2022-06-30 was $302.00K.
- OLEMA PHARMACEUTICALS, INC. increase (decrease) in other operating assets for the quarter ending 2022-03-31 was $240.00K.
- OLEMA PHARMACEUTICALS, INC. increase (decrease) in other operating assets for fiscal 2022 was $1.11M, a 3613.33% increase from fiscal 2021.
- OLEMA PHARMACEUTICALS, INC. increase (decrease) in other operating assets for fiscal 2021 was $30.00K, a 94.08% decline from fiscal 2020.
- OLEMA PHARMACEUTICALS, INC. increase (decrease) in other operating assets for fiscal 2020 was $507.00K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $572.00K derived: sum of 2 quarters · filed 2023-03-09 | $874.00K derived: sum of 3 quarters · filed 2023-03-09 | $1.11M 10-K · filed 2023-03-09 |
| 2022-09-30 | $572.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $874.00K derived: sum of 2 quarters · filed 2022-11-08 | $1.11M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $302.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $542.00K 10-Q · filed 2022-08-09 | ||
| 2022-03-31 | $240.00K 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | $30.00K 10-K · filed 2023-03-09 | |||
| 2020-12-31 | $507.00K 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |